Transgene S.A.
- Biotech or pharma, therapeutic R&D
Transgene (Euronext: TNG) is a publicly traded French biopharmaceutical company focused on discovering and developing virus-based immunotherapies for the treatment of cancer, including individualized vaccines and oncolytic viruses.